Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Mimedx (MDXG) over the last 13 years, with Q3 2025 value amounting to 0.17%.

  • Mimedx's Return on Invested Capital fell 3400.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year decrease of 3400.0%. This contributed to the annual value of 0.21% for FY2024, which is 5200.0% down from last year.
  • According to the latest figures from Q3 2025, Mimedx's Return on Invested Capital is 0.17%, which was down 3400.0% from 0.15% recorded in Q2 2025.
  • In the past 5 years, Mimedx's Return on Invested Capital registered a high of 0.74% during Q3 2023, and its lowest value of 0.85% during Q1 2021.
  • Its 5-year average for Return on Invested Capital is 0.02%, with a median of 0.15% in 2025.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first crashed by -7200bps in 2021, then surged by 15200bps in 2023.
  • Over the past 5 years, Mimedx's Return on Invested Capital (Quarter) stood at 0.16% in 2021, then tumbled by -221bps to 0.5% in 2022, then surged by 235bps to 0.67% in 2023, then crashed by -68bps to 0.22% in 2024, then dropped by -21bps to 0.17% in 2025.
  • Its Return on Invested Capital stands at 0.17% for Q3 2025, versus 0.15% for Q2 2025 and 0.19% for Q1 2025.